Recurrent pulmonary embolism in a patient with asthma

Respiration

Volumn 71, Issue 4, 2004, Pages 428-

  Divac, A ^a,b   Djordjevic, V ^a,b   Jovanovic, D ^a   Miljic, P ^a   Nagorni Obradovic, L J ^a   Nikolic, A ^a   Rakicevic, L J ^a   Radojkovic, D ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Institute for Molecular Genetics and Genetic Engineering   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ASTHMA; CASE REPORT; CLINICAL FEATURE; FEMALE; FRACTURE; GENETIC SUSCEPTIBILITY; HUMAN; LABORATORY TEST; LETTER; LUNG EMBOLISM; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SMOKING; SYMPTOM; VEIN THROMBOSIS;

EID: 4444374089     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079653     Document Type: Letter

References (5)

1. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG: ΔF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998;351: 1911-1913.
2. Hooper CW, De Staercke C: The relationship between FV Leiden and pulmonary embolism. Respir Res 2002;3:8-11.
3. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C, Jacobson K, Weinstein DL, Metcalf EL, Pollard HB: Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NfkappaB pathway. Mol Med 2001;7:523-534.
4. Reid DW, Ward C, Wang N, Zhang L, Bish R, Orsida B, Walters EH: Possible anti-inflammatory effect of salmetrol against interleukin-8 and neutrophil activation in asthma in vivo. Eur Respir J 2003;21:994-999.
5. van Aken BE, Reitsma PH, Rosendaal FR: Interleukin 8 and venous thrombosis: Evidence for a role of inflammation in thrombosis. Br J Haematol 2002;116:173-177.